High-dose chemotherapy with autologous stem cell support does not improve outcome in the first-line treatment of aggressive non-Hodgkin lymphoma - Results of a comprehensive meta-analysis

被引:0
|
作者
Greb, A
Bohlius, J
Schwarzer, G
Schiefer, D
Engert, A
机构
[1] German Cochrane Ctr, Inst Med Biometry & Med Informat, Freiburg, Germany
[2] Univ Cologne, Dept Internal Med 1, Cochrane Haematol Malignancies Grp, Cologne, Germany
关键词
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
068
引用
收藏
页码:55 / 55
页数:1
相关论文
共 50 条
  • [1] High-dose chemotherapy with autologous stem cell support in first-line treatment of aggressive non-Hodgkin lymphoma - Results of a comprehensive meta-analysis
    Greb, Alexander
    Bohlius, Julia
    Trelle, Sven
    Schiefer, Daniel
    De Souza, Carmino A.
    Gisselbrecht, Christian
    Lntragumtornchai, Tanin
    Kaiser, Ulrich
    Kluin-Nelemans, Hanneke C.
    Martelli, Maurizio
    Milpied, Noel Jean
    Santini, Gino
    Verdonck, Leo F.
    Vitolo, Umberto
    Schwarzer, Guido
    Engert, Andreas
    CANCER TREATMENT REVIEWS, 2007, 33 (04) : 338 - 346
  • [2] High-dose chemotherapy with autologous stem cell support is not superior to conventional-dose chemotherapy in the first-line treatment of aggressive non-Hodgkin lymphoma - Results of a comprehensive meta-analysis.
    Greb, A
    Schiefer, DH
    Bohlius, J
    Schwarzer, G
    Engert, A
    BLOOD, 2004, 104 (11) : 263A - 263A
  • [3] High-dose chemotherapy followed by autologous stem cell transplantation as first-line therapy in aggressive non-Hodgkin's lymphoma:: a meta-analysis
    Strehl, J
    Mey, U
    Glasmacher, A
    Djulbegovic, B
    Mayr, C
    Gorschlüter, M
    Ziske, C
    Schmidt-Wolf, IGH
    HAEMATOLOGICA, 2003, 88 (11) : 1304 - 1315
  • [4] Meta-analysis of randomised trials comparing high-dose chemotherapy with autologous stem cell support as part of first-line therapy with conventional chemotherapy in aggressive non-Hodgkin lymphoma - First results.
    Greb, A
    Bohlius, J
    Schiefer, D
    Schwarzer, G
    Engert, A
    BLOOD, 2003, 102 (11) : 734A - 734A
  • [5] HIGH DOSE CHEMOTHERAPY WITH AUTOLOGOUS STEM CELL SUPPORT IN FIRST LINE TREATMENT OF AGGRESSIVE NON HODGKIN LYMPHOMA: RESULTS OF AN INDIVIDUAL PATIENT DATA META-ANALYSIS
    Brillant, C.
    Schwarzer, G.
    Bohlius, J.
    Greb, A.
    Trelle, S.
    Haioun, C.
    De Souza, A.
    Gisselbrecht, C.
    Intragumtornchai, T.
    Kaiser, U.
    Kluin-Nelemans, C.
    Martelli, M.
    Milpied, N.
    Verdonck, F.
    Vitolo, U.
    Engert, A.
    Schulz, H.
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2009, 94 : 392 - 392
  • [6] Standard chemotherapy is superior to high-dose chemotherapy with autologous stem cell transplantation on overall survival as the first-line therapy for patients with aggressive non-Hodgkin lymphoma: a meta-analysis
    Jing Wang
    Ping Zhan
    Jian Ouyang
    Bing Chen
    Rongfu Zhou
    Yonggong Yang
    Medical Oncology, 2011, 28 : 822 - 828
  • [7] Standard chemotherapy is superior to high-dose chemotherapy with autologous stem cell transplantation on overall survival as the first-line therapy for patients with aggressive non-Hodgkin lymphoma: a meta-analysis
    Wang, Jing
    Zhan, Ping
    Ouyang, Jian
    Chen, Bing
    Zhou, Rongfu
    Yang, Yonggong
    MEDICAL ONCOLOGY, 2011, 28 (03) : 822 - 828
  • [8] High-dose chemotherapy with autologous stem cell transplantation in the first line treatment of aggressive Non-Hodgkin Lymphoma (NHL) in adults
    Greb, A.
    Bohlius, J.
    Schiefer, D.
    Schwarzer, G.
    Schulz, H.
    Engert, A.
    COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2008, (01):
  • [9] Feasibility of high-dose chemotherapy without stem cell support as a first-line treatment for non-Hodgkin's aggressive lymphoma: A pilot study
    Inoue, R
    Natazuka, T
    Shimoyama, M
    Tamekane, A
    Kajimoto, Y
    Iwata, N
    Matsuoka, H
    Chihara, K
    Matsui, T
    LEUKEMIA & LYMPHOMA, 2000, 36 (3-4) : 315 - 321
  • [10] Cost Effectiveness of High-Dose Chemotherapy with Autologous Stem Cell Support as Initial Treatment of Aggressive Non-Hodgkin's Lymphoma
    Fagnoni, Philippe
    Milpied, Noel
    Limat, Samuel
    Deconinck, Eric
    Nerich, Virginie
    Foussard, Charles
    Colombat, Philippe
    Harousseau, Jean-Luc
    Woronoff-Lemsi, Marie-Christine
    PHARMACOECONOMICS, 2009, 27 (01) : 55 - 68